Publications by authors named "P N Fisher"

Objective: Although extant research points to NonVerbal Learning Disability (NVLD) as a distinct disorder, it is not included in the diagnostic nomenclatures, and there is heterogeneity in how it is defined. We formed a working group to gain consensus on a standard DSM type definition for NVLD, a necessary first step for proposing its inclusion in future DSMs and renamed the disorder to better reflect the core deficit - visual-spatial problems.

Method: An iterative process was used to reach consensus on a DSM style criteria set that reconceptualizes NVLD as Developmental Visual-Spatial Disorder (DVSD).

View Article and Find Full Text PDF

Background: The psychological impact of surviving an admission to an intensive care unit (ICU) with COVID-19 is uncertain. The objective of the study was to assess the prevalence of anxiety, depression and post-traumatic stress disorder (PTSD) symptoms in ICU survivors treated for COVID-19 infection, and identify risk factors for psychological distress.

Methods: This observational study was conducted at 52 ICUs in the United Kingdom.

View Article and Find Full Text PDF

Background: The training of clinical psychologists is conducted by staff, trainees, service users and carers. Often those working in clinical psychology do so due to their own lived experiences. These stakeholders may require having to navigate both personal and professional identities.

View Article and Find Full Text PDF

Objective: This study explored parents' experiences of the transition of responsibility to their child for healthcare decisions relating to their cleft lip and/or palate (CL/P).

Methods: Online semi-structured interviews were conducted with 11 participants (six females and five males, aged 41 to 60 years). They were parents of young people who had decided whether to undergo orthognathic surgery.

View Article and Find Full Text PDF

The continuous rise in skin cancer incidence highlights an imperative for improved skin cancer prevention. Topical calcipotriol-plus-5-fluorouracil (calcipotriol-plus-5-FU) immunotherapy effectively eliminates precancerous skin lesions and prevents squamous cell carcinoma (SCC) in patients. However, its mechanism of action remains unclear.

View Article and Find Full Text PDF